Alzheimer’s disease is commonly thought of as an older person’s illness. But new research from Columbia University and the ...

A team of scientists including UCL researchers has tested four anti-amyloid Alzheimer's therapeutics to find out how the ...

A new study suggests that risk factors and biomarkers related to Alzheimer's disease are associated with cognition much earlier in life than previously recognized. The study highlights significant ...

University of New Mexico Health Sciences researchers hope to launch human clinical trials in their quest for a vaccine to ...

People with Alzheimer's disease may retain their ability to empathize, despite declines in other social abilities, finds a ...

Dr. Joel Salinas, a behavioral neurologist and associate professor at NYU Grossman School of Medicine, discusses what’s ...

Across nearly 2 million people with a mean age of 49, metabolic syndrome was tied to a 24% higher risk of all-cause ...

Conventional testing procedures often require a "spinal tap" in which a needle is inserted into the lower spine to retrieve ...

A study involving over 1,700 participants from five hospitals across Barcelona, Sweden, and Italy has confirmed the ...

A randomized, placebo-controlled clinical trial is underway called Valacyclovir Treatment of Alzheimer’s Disease but results ...

A commonly prescribed sleeping pill could be a powerful tool in preventing Alzheimer's disease, according to recently ...

People with Alzheimer's disease may retain their ability to empathize, despite declines in other social abilities, finds a new study.